Julie Yabu is a Nephrology physician affiliated with University of California, Los Angeles. OpenAlex indexes 44 publications with 1,751 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Medical Plaza Suite 565
Los Angeles, CA 900952202
Telephone
310-267-2555Registry record last updated 19 Jul 2019.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
29.9%Corticosteroid15.6%Prednisone100%Part D≥33 patientsProton pump inhibitor12.1%Pantoprazole Sodium100%Part D≥32 patients+ 1 more class in this area
Anti-infectives
26.4%Short-acting sulfonamides13.1%Sulfamethoxazole-Trimethoprim100%Part D≥32 patientsCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor6.2%Valganciclovir Hcl100%Part D≥23 patients+ 2 more classes in this area
Cardiovascular
20.1%Calcium channel blocker8%Nifedipine Er100%Part D≥17 patientsStatin6.8%Atorvastatin Calcium69%Rosuvastatin Calcium31%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2012–2015 per NIH RePORTER. The latest:
- Improving Kidney Transplant Outcomes Using Novel B-cell Immune Profiling
Stanford University
FY2015$132,624K23AI104401 - Improving Kidney Transplant Outcomes Using Novel B-cell Immune Profiling
Stanford University
FY2014$132,120K23AI104401 - Improving Kidney Transplant Outcomes Using Novel B-cell Immune Profiling
Stanford University
FY2013$131,728K23AI104401
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Batch Correction and Comparison of Intracellular Signaling Among Multiple Rheumatic and Inflammatory Diseases
Journal of Probability and Statistics
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Gregg Fonarow, MD
University of California, Los Angeles
Dennis Slamon, MD
University of California, Los Angeles
Tomas Ganz, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”